Alte Drogen – neue Erkenntnisse? Neue Strategien zur adjuvanten Behandlung von Harnwegsinfekten mit Schachtelhalmkraut^[*]

 

 Buy Article Permissions and Reprints

ZUSAMMENFASSUNG

Tamm-Horsfall-Protein (syn. THP, Uromodulin) ist ein im distalen Tubulus der Niere sekretiertes Protein, welches in der Lage ist, uropathogene E. coli zu binden und somit deren Ausscheidung zu verbessern und die Pathogen-Wirt-Interaktion zu reduzieren. Die Erhöhung der Sekretion von THP durch spezielle Induktoren stellt eine neue und innovative Therapiestrategie zur Prophylaxe und/oder Behandlung von Harnwegsinfekten dar.

In einer biomedizinischen Studie mit n=10 Probanden wurde der Einfluss eines Schachtelhalmkraut-Trockenextraktes (DEV 4–7:1, Auszugsmittel Wasser) aus Equisetum arvense L. nach siebentägiger Einnahme auf die THP-Sekretion untersucht. Die jeweilige Tagesdosis des Extraktes (1,30 g) entspricht 7,2 g Droge und somit der Dosierungsempfehlung des HMPC. Die Quantifizierung der THP-Konzentrationen in den Einzelproben und in gepooltem Urin erfolgte aus den an den Studientagen 0, 3, 6 und 8 gesammelten morgendlichen Mittelstrahlurinen mittels validiertem ELISA. Zusätzlich wurden die Elektrolyte in allen Urinproben sowie der Kreatinin-Gehalt quantifiziert. Routineparameter wurden mittels Urinteststreifen bestimmt.

Das THP/Kreatinin [µg/mg]-Verhältnis (= THP-Ausscheidungsrate) unter der Anwendung von Schachtelhalmextrakt zeigte signifikante Steigerungen über die jeweilige Anwendungsdauer (bis zu 400%, bezogen auf den Ausgangswert des Tag-0-Urins). Ebenfalls zeigte sich eine diuretische Wirkung, die über die erniedrigte Osmolarität und die erhöhte Elektrolytausscheidung (Na⁺, Cl^–, Ca²⁺ sowie Silicium-Derivate) erkennbar war. Weiterhin wurde der Einfluss der Urinproben im ex-vivo-Assay auf die Adhäsion von UPEC (Stamm NU14) auf humane T24-Blasenzellen untersucht. Dabei zeigte sich, dass die relative bakterielle Adhäsion an die Wirtszellen im Laufe der Schachtelhalmbehandlung signifikant abnahm. Die Hemmung der bakteriellen Adhäsion korreliert sehr gut mit der THP-Zunahme in den jeweiligen Urinproben. Der über LC-MS vollständig charakterisierte Schachtelhalmextrakt zeigte selbst keine anti-adhäsiven Eigenschaften, sodass daraus zurückgeschlossen werden kann, dass entweder die renale Stimulation von THP oder die induzierte Diurese zu einer Verringerung der bakteriellen Adhäsion führt. Die vorliegenden Untersuchungen könnten dazu dienen, die traditionelle Verwendung von Ackerschachtelhalm bei unkomplizierten Harnwegsinfektionen zu rationalisieren.

Abstract

Tamm-Horsfall protein (syn. THP, Uromodulin) is a protein secreted in the distal tubule of the kidney, which is able to bind uropathogenic E. coli and thus improves the bacterial excretion and reduces the pathogen-host interaction. Increasing the secretion of THP by specific inducers represents a novel and innovative therapeutic strategy for the prophylaxis and/or treatment of urinary tract infections.

In a biomedical study with n=10 subjects the influence of a dry extract of horsetail herb (herb extract ration 4–7:1, solvent water) from Equisetum arvense L. on THP secretion was investigated after seven days of oral ingestion. The respective daily dose of the extract (1.30 g) corresponds to 7.2 g of the herbal drug material and thus to the dosage recommendation of the HMPC. Quantification of THP concentrations in individual samples and pooled urine were performed from morning midstream urines, collected on study days 0, 3, 6, and 8, using validated ELISA. In addition, electrolytes in all urine samples and creatinine levels were quantified. Routine parameters were determined by urine test strips.

The THP/creatinine [µg/mg] ratio (= THP excretion rate) under application of horsetail extract showed significant increases over the respective application periods (up to 400%, relative to the baseline day 0 urine value). A diuretic effect was evident by decreased osmolarity and increased electrolyte excretion (Na⁺, Cl^–, Ca²⁺, also Silicon derivatives). Furthermore, the influence of the urine samples within a specific flow cytometric ex vivo assay on the adhesion of fluorescent-labelled UPEC (strain NU14) to human T24 bladder cells was investigated. The data indicated that the relative bacterial adhesion to host cells decreased significantly during the course of horsetail treatment. The inhibition of bacterial adhesion correlated well with the THP increase in the respective urine samples. The horsetail extract itself, fully characterized by LC-MS, did not show any anti-adhesive properties, so it can be concluded that either renal stimulation of THP or induced diuresis explains a decrease in bacterial adhesion. The present studies may serve to rationalize the traditional use of horsetail herb in uncomplicated urinary tract infections.

¹ Hinweis: Dieser Beitrag stellt eine Zusammenfassung einer wissenschaftlichen Originalpublikation dar (DOI: 10.1016/j.phymed.2022.154302) und dient ausschließlich der Information von interessiertem Fachpublikum, welches nicht unbedingt Zugang zu den wissenschaftlichen Zeitschriften hat, für das aber die Information im beruflichen Alltag von Interesse ist.

Publication History

Article published online:
15 May 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• Literatur

• 1 Foxman B, Brown P.. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am 2003; 17: 227-241 DOI: 10.1016/S0891-5520(03)00005-9.
  CrossrefPubMedGoogle Scholar
• 2 Foxman B.. The epidemiology of urinary tract infection. Nat Rev Urol 2010; 7: 653-660 DOI: 10.1038/nrurol.2010.190.
  CrossrefPubMedGoogle Scholar
• 3 Flores-Mireles AL, Walker JN, Caparon M. et al. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 2015; 13: 269-284 DOI: 10.1038/nrmicro3432.
  CrossrefPubMedGoogle Scholar
• 4 Deutsche Gesellschaft für Urologie, Hrsg. Interdisziplinäre S3-Leitlinie: Epidemiologie, Diagnostik, Therapie, Prävention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten. 2017. Langversion 1.1-2 [AWMF Registernr.: 043/044]. Im Internet https://www.awmf.org/leitlinien/detail/ll/043-044.html; cited: March 1, 2023
  PubMed
• 5 Stapleton AE, Au-Yeung M, Hooton TM. et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis 2011; 52: 1212-1217 DOI: 10.1093/cid/cir183.
  CrossrefPubMedGoogle Scholar
• 6 Mobley HL, Alteri CJ.. Development of a vaccine against Escherichia coli urinary tract infections. Pathogens 2015; 5: 1 DOI: 10.3390/pathogens5010001.
  CrossrefPubMedGoogle Scholar
• 7 Appeldoorn CC, Joosten JA, Ait el Maate F. et al. Novel multivalent mannose compounds and their inhibition of the adhesion of type 1 fimbriated uropathogenic E. coli . Tetrahedron: Asymmetry 2005; 16: 361-372 DOI: 10.1016/j.tetasy.2004.11.014.
  CrossrefPubMedGoogle Scholar
• 8 Beydokhti SS, Stork C, Dobrindt U. et al. Orthosipon stamineus extract exerts inhibition of bacterial adhesion and chaperon-usher system of uropathogenic Escherichia coli – a transcriptomic study. Appl Microbiol Biotechnol 2019; 103: 8571-8584 DOI: 10.1007/s00253-019-10120-w.
  CrossrefPubMedGoogle Scholar
• 9 Spaulding CN, Hultgren SJ.. Adhesive pili in UTI pathogenesis and drug development. Pathogens 2016; 5: 30 DOI: 10.3390/pathogens5010030.
  CrossrefPubMedGoogle Scholar
• 10 Spiegler V, Gierlikowska B, Saenger T. et al. Root extracts from Ononis spinosa inhibit IL-8 release via interactions with Toll-Like receptor 4 and lipopolysaccharide. Front Pharmacol 2020; 11: 889 DOI: 10.3389/fphar.2020.00889.
  CrossrefPubMedGoogle Scholar
• 11 Beydokthi SS, Sendker J, Brandt S. et al. Traditionally used medicinal plants against uncomplicated urinary tract infections: Hexadecyl coumaric acid ester from the rhizomes of Agropyron repens (L.) P. Beauv. with antiadhesive activity against uropathogenic E. coli . Fitoterapia 2017; 117: 22-27 DOI: 10.1016/j.fitote.2016.12.010.
  CrossrefPubMedGoogle Scholar
• 12 Deipenbrock M, Scotti F, Mo B. et al. Seven-day oral intake of Orthosiphon stamineus leaves infusion exerts antiadhesive ex vivo activity against uropathogenic E. coli in urine samples. Planta Med 2021; [online ahead of print] DOI: 10.1055/a-1585-6322.
  Article in Thieme ConnectPubMedGoogle Scholar
• 13 Negro EJ, Sendker J, Stark T. et al. Phytochemical and functional analysis of horseradish (Armoracia rusticana) fermented and non-fermented root extracts. Fitoterapia 2022; 162: 105282 DOI: 10.1016/j.fitote.2022.105282.
  CrossrefPubMedGoogle Scholar
• 14 Schindler E, Zipp H, Marth I.. Comparative clinical studies on non-specific urinary tract infections with an enzyme-glycoside mixture obtained from horseradish roots (Cochlearia armoracia L.). Arzneimittelforschung 1960; 10: 919-921
  PubMedGoogle Scholar
• 15 Sarshar S, Brandt S, Asadi Karam MR. et al. Aqueous extract from Orthosiphon stamineus leaves prevents bladder and kidney infection in mice. Phytomedicine 2017; 28: 1-9 DOI: 10.1016/j.phymed.2017.02.009.
  CrossrefPubMedGoogle Scholar
• 16 Scharf B, Sendker J, Dobrindt U. et al. Influence of cranberry extract on Tamm-Horsfall protein in human urine and its antiadhesive activity against uropathogenic Escherichia coli . Planta Med 2018; 85: 126-138 DOI: 10.1055/a-0755-7801.
  Article in Thieme ConnectPubMedGoogle Scholar
• 17 Rafsanjany N, Senker J, Brandt S. et al. In vivo consumption of cranberry exerts ex vivo antiadhesive activity against FimH-dominated uropathogenic Escherichia coli: a combined in vivo, ex vivo, and in vitro study of an extract from Vaccinium macrocarpon . J Agric Food Chem 2015; 63: 8804-8818 DOI: 10.1021/acs.jafc.5b03030.
  CrossrefPubMedGoogle Scholar
• 18 Tokonami N, Takata T, Beyeler J. et al. Uromodulin is expressed in the distal convoluted tubule, where it is critical for regulation of the sodium chloride cotransporter NCC. Kidney Int 2018; 94: 701-715 DOI: 10.1016/j.kint.2018.04.021.
  CrossrefPubMedGoogle Scholar
• 19 Devuyst O, Bochud M.. Uromodulin, kidney function, cardiovascular disease, and mortality. Kidney Int 2015; 88: 944-946 DOI: 10.1038/ki.2015.267.
  CrossrefPubMedGoogle Scholar
• 20 Weiss GL, Stanisich JJ, Sauer MM. et al. Architecture and function of human uromodulin filaments in urinary tract infections. Science 2020; 369: 1005-1010 DOI: 10.1126/science.aaz9866.
  CrossrefPubMedGoogle Scholar
• 21 Bjugn R, Flood PR.. Scanning electron microscopy of human urine and purified Tamm-Horsfall's glycoprotein. Scand J Urol Nephrol 1988; 22: 313-315 DOI: 10.3109/00365598809180806.
  CrossrefPubMedGoogle Scholar
• 22 Bokhove M, Nishimura K, Brunati M. et al. A structured interdomain linker directs self-polymerization of human uromodulin. Proc Natl Acad Sci U S A 2016; 113: 1552-1557 DOI: 10.1073/pnas.1519803113.
  CrossrefPubMedGoogle Scholar
• 23 Serafini-Cessi F, Malagolini N, Hoops TC. et al. Biosynthesis and oligosaccharide processing of human Tamm-Horsfall glycoprotein permanently expressed in HeLa cells. Biochem Biophys Res Commun 1993; 194: 784-790 DOI: 10.1006/bbrc.1993.1890.
  CrossrefPubMedGoogle Scholar
• 24 van Rooijen JJ, Voskamp AF, Kamerling JP. et al. Glycosylation sites and site-specific glycosylation in human Tamm-Horsfall glycoprotein. Glycobiology 1999; 9: 21-30 DOI: 10.1093/glycob/9.1.21.
  CrossrefPubMedGoogle Scholar
• 25 Bates JM, Raffi HM, Prasadan K. et al. Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int 2004; 65: 791-797 DOI: 10.1111/j.1523-1755.2004.00452.x.
  CrossrefPubMedGoogle Scholar
• 26 Liu Y, Mo L, Goldfarb DS. et al. Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein. Am J Physiol Renal Physiol 2010; 299: F469-478 DOI: 10.1152/ajprenal.00243.2010.
  CrossrefPubMedGoogle Scholar
• 27 Mo L, Huang H-Y, Zhu X-H. et al. Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation. Kidney Int 2004; 66: 1159-1166 DOI: 10.1111/j.1523-1755.2004.00867.x.
  CrossrefPubMedGoogle Scholar
• 28 Jaggi M, Nakagawa Y, Zipperle L. et al. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function. Urol Res 2007; 35: 55-62 DOI: 10.1007/s00240-007-0083-7.
  CrossrefPubMedGoogle Scholar
• 29 Jefferson A, Reynolds TM, Elves A. et al. Patients with recurrent renal stones have a physico-chemically altered urinary Tamm-Horsfall glycoprotein profile. Ann Clin Biochem 1996; 33: 540-544 DOI: 10.1177/000456329603300609.
  CrossrefPubMedGoogle Scholar
• 30 Parsons CL, Rajasekaran M, Arsanjani AH. et al. Role of sialic acid in urinary cytoprotective activity of Tamm-Horsfall protein. Urology 2007; 69: 577-581 DOI: 10.1016/j.urology.2006.12.026.
  CrossrefPubMedGoogle Scholar
• 31 Stein P, Rajasekaran M, Parsons CL.. Tamm-Horsfall protein protects urothelial permeability barrier. Urology 2005; 66: 903-907 DOI: 10.1016/j.urology.2005.05.021.
  CrossrefPubMedGoogle Scholar
• 32 Tosukhowong P, Kulpradit P, Chaiyarit S. et al. Lime powder treatment reduces urinary excretion of total protein and transferrin but increases uromodulin excretion in patients with urolithiasis. Urolithiasis 2018; 46: 257-264 DOI: 10.1007/s00240-017-0986-x.
  CrossrefPubMedGoogle Scholar
• 33 European Medicines Agency, Committee on Herbal Medicinal Products. European Union herbal monograph on Equisetum arvense L., herba. EMA/HMPC/278091/2015. London: EMA; 2016
  PubMed
• 34 Kommission E.. Equiseti herba, Schachtelhalmkraut. Bundesanzeiger Nr. 173 vom 18.09.1986.
  PubMedGoogle Scholar
• 35 Mo B, Sendker J, Herrmann F. et al. Aqueous extract from Equisetum arvense stimulates the secretion of Tamm-Horsfall protein in human urine after oral intake. Phytomedicine 2022; 104: 154302 DOI: 10.1016/j.phymed.2022.154302.
  CrossrefPubMedGoogle Scholar
• 36 Cortinovis C, Caloni F.. Alkaloid-containing plants poisonous to cattle and horses in Europe. Toxins (Basel) 2015; 7: 5301-5307 DOI: 10.3390/toxins7124884.
  CrossrefPubMedGoogle Scholar
• 37 Reyes AJ.. Effects of diuretics on outputs and flows of urine and urinary solutes in healthy subjects. Drugs 1991; 41: 35-59 DOI: 10.2165/00003495-199100413-00006.
  CrossrefPubMedGoogle Scholar
• 38 Geisslinger G, Menzel S, Gudermann T, Hinz B, Ruth P.. Mutschler Arzneimittelwirkungen. Pharmakologie – Klinische Pharmakologie – Toxikologie. 11. Aufl. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2020
  Google Scholar